Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (NCT03772028)
Phase III Randomized Clinical Trial for Stage III Epithelial Ovarian Cancer Randomizing Between Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy
🩺 Plain-English Summary (8th-Grade Level)
stage III epithelial ovarian cancer randomizing between primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy
Who can join: Review the eligibility criteria below.
Location: City of Hope — Duarte, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (28 Sites)
Showing the first 25 of 28 sites.
- City of Hope — Duarte, California
- MSKCC New York — New York, New York
- Rigshospitalet Copenhagen — Copenhagen,
- CHU de Besancon — Besançon,
- Institut Bergonié — Bordeaux,
- o Institut Bergonié, Bordeaux — Bordeaux,
- CHU Lille — Lille,
- Centre Leon Berard, Lyon — Lyon,
- CHU Lyon — Lyon,
- Institut du Cancer Montpellier — Montpellier,
- Institut de Cancerologie de l'Ouest, ICO Nantes) — Nantes,
- Institut Curie Paris — Paris,
- CHRU Strasbourg — Strasbourg,
- Oncopole, Institute Universitaire du Cancer de Toulouse (IUCT Toulouse) — Toulouse,
- Mater Misericordiae University Hospital, Dublin — Dublin,
- Policlinico Sant'Orsola, Bologna — Bologna,
- Fondazione Policlinico A Gemelli IRCCS — Roma,
- Antoni van leeuwenhoek — Amsterdam, North Holland
- Amsterdam UMC — Amsterdam,
- Catharina Hospital — Eindhoven,
- Medisch Spectrum Twente — Enschede,
- UMCG — Groningen,
- Leiden University Medical Center (LUMC) — Leiden,
- Maastricht UMC+ — Maastricht,
- Radboud MC — Nijmegen,
📞 Contact the Study Coordinator
Phone: (800) 826-4673
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Ovarian Cancer
- Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy — New York, New York
- Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer — Pittsburgh, Pennsylvania
- Trial on Radical Upfront Surgery in Advanced Ovarian Cancer — New York, New York
- Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302) — Little Rock, Arkansas
- NeoVax With Nivolumab in Patients With Ovarian Cancer — Boston, Massachusetts
Explore by condition: All Ovarian Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.